Isotope

CNL and AECL Continue Pursuit of Closer Ties With Canada’s Academic Community Through MOU With McMaster University

Retrieved on: 
Tuesday, November 29, 2022

CHALK RIVER, Ontario, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology laboratory, is pleased to announce that it has signed a Memorandum of Understanding (MOU) with Atomic Energy of Canada Limited (AECL), Canada’s nuclear Crown Corporation, and McMaster University to pursue collaborative research opportunities. The MOU represents continued progress for Canada’s national nuclear laboratories as it works to build closer ties with Canada’s academic community, and is the third agreement signed in recent weeks with a leading Canadian university that is designed to advance collaborative research in health and environmental sciences, clean energy and nuclear safety.

Key Points: 
  • That is the driving force behind CNLs ongoing outreach and engagement with the academic community, and we are thrilled to further grow our relationship with McMaster University as part of that effort.
  • This agreement is a key step on our path forward, said Amy Gottschling, AECL Vice President, Science, Technology and Commercial Oversight.
  • Together, CNL, AECL and McMaster operate some of the most unique and advanced nuclear facilities and research laboratories, not just in Canada, but around the world.
  • Located in Hamilton, Ontario, McMaster University is among Canadas most research-intensive universities, and the nations preeminent nuclear research institution.

CNL, AECL and Ontario Tech University Partner to Pursue Collaborative Research

Retrieved on: 
Monday, November 28, 2022

Working in partnership with Ontario Tech University enables us to pool our financial resources, accelerate early-stage research, facilitate the transfer of knowledge, and work together to address the needs of the nuclear industry and the federal government.

Key Points: 
  • Working in partnership with Ontario Tech University enables us to pool our financial resources, accelerate early-stage research, facilitate the transfer of knowledge, and work together to address the needs of the nuclear industry and the federal government.
  • AECL is proud to announce its partnership today with Ontario Tech University, an engaged partner that attracts the best and brightest students and researchers, says Dr. Amy Gottschling, Vice-President, Science, Technology & Commercial Oversight, AECL.
  • As part of our growing nexus, AECL, CNL and Ontario Tech will tackle our nations greatest challenges.
  • Ontario Tech University is excited to enter this dynamic and expanding collaborative phase with both AECL and CNL in strategic areas that include small modular reactors, hydrogen, and integrated energy systems, commented Dr. Les Jacobs, Vice-President of Research and Innovation at Ontario Tech University.

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

Retrieved on: 
Monday, November 28, 2022

NEW YORK, Nov. 28, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today announced the successful initial public offering ("IPO") of ASP Isotopes ("ASPI"). ASPI priced its initial public offering of 1,250,000 shares of its common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $5.0 million before deducting underwriting discounts, commissions, and other offering expenses.

Key Points: 
  • Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI
    NEW YORK, Nov. 28, 2022 /PRNewswire/ --AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today announced the successful initial public offering ("IPO") of ASP Isotopes ("ASPI").
  • ASPI priced its initial public offering of 1,250,000 shares of its common stock at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $5.0 million before deducting underwriting discounts, commissions, and other offering expenses.
  • Mr. Anthony Hayes, CEO of AIkido stated, "As a shareholder of ASP Isotopes, we want to congratulate the company and their CEO, Paul Mann on successfully listing on NASDAQ.
  • We congratulate Paul and his team for getting this public offering over the line.

CNL, AECL and the University of Ottawa Sign MOU to Pursue Collaborative Research Opportunities

Retrieved on: 
Thursday, November 24, 2022

CHALK RIVER, Ontario, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology laboratory, is pleased to announce that it has signed a Memorandum of Understanding (MOU) with Atomic Energy of Canada Limited (AECL), Canada’s nuclear Crown Corporation, and the University of Ottawa to identify and pursue collaborative research opportunities. Building on decades of work together, the MOU formalizes what has been a longstanding relationship between the organizations in order to facilitate joint research projects, foster the professional development of highly qualified personnel, and encourage shared access to specialized infrastructure, all to advance research in health and environmental sciences, clean energy and nuclear safety.

Key Points: 
  • Alongside CNL, AECL is incredibly excited to enter into this agreement with the University of Ottawa, an organization who shares our passion for research, innovation and entrepreneurship, commented Amy Gottschling, Vice-President, Science, Technology & Commercial Oversight, AECL.
  • This objective is at the heart of this agreement with the University of Ottawa, and we are confident that our work will yield results that offer real, meaningful benefits for Canadians.
  • We share their determination to be agile and to seize every opportunity to continually push back the frontiers of research and development.
  • Today it delivers value for Canadians through supporting 14 federal departments and agencies, as well as the global nuclear industry.

General Atomics Awarded Funding for Tokamak Research in Facilities Around the World

Retrieved on: 
Thursday, November 17, 2022

San Diego, CA, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Five researchers at General Atomics (GA) have been awarded funding from the U.S. Department of Energy (DOE) to conduct experimental research in fusion energy, which will be performed at tokamak facilities in the U.S. and around the world.

Key Points: 
  • San Diego, CA, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Five researchers at General Atomics (GA) have been awarded funding from the U.S. Department of Energy (DOE) to conduct experimental research in fusion energy, which will be performed at tokamak facilities in the U.S. and around the world.
  • This funding will enable important collaborative research as the world looks to fusion energy, said Dr. Wayne Solomon, Vice President of Magnetic Fusion Energy at General Atomics.
  • DOEs support of the fusion community and emphasis on research to address gaps in fusion science and technology will help deliver fusion energy faster.
  • These projects are important for creating feasible control capabilities at future electricity-producing fusion facilities, and DOE funding makes them possible.

A group of journalists from HT investigates the impact of Fukushima's controversial plan to dump water into the ocean

Retrieved on: 
Thursday, November 24, 2022

A group of international journalists led by Global Think Agency investigates and analyzes the impact of the controversial plan to discharge water from Fukushima into the sea.

Key Points: 
  • A group of international journalists led by Global Think Agency investigates and analyzes the impact of the controversial plan to discharge water from Fukushima into the sea.
  • It is currently unknown how the long-lived radioactive isotopes contained in the contaminated water will interact with marine biology, this situation is "unprecedented".
  • Tepco is also accused of irresponsibly delaying the cooling of the reactors with salt water because it was going to ruin them beyond repair.
  • HT is a global agency specializing in developing documentary, research and entertainment content.

Blue Earth Diagnostics Highlights Upcoming Presentation of Results from Phase 3 LIGHTHOUSE Study of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

Retrieved on: 
Monday, November 21, 2022

Blue Earth Diagnostics acquired exclusive, worldwide rights to rhPSMA diagnostic imaging technology from Scintomics GmbH in 2018, and therapeutic rights in 2020, and has sublicensed the therapeutic application to its sister company Blue Earth Therapeutics.

Key Points: 
  • Blue Earth Diagnostics acquired exclusive, worldwide rights to rhPSMA diagnostic imaging technology from Scintomics GmbH in 2018, and therapeutic rights in 2020, and has sublicensed the therapeutic application to its sister company Blue Earth Therapeutics.
  • Blue Earth Diagnostics has completed two Phase 3 clinical studies evaluating the safety and diagnostic performance of 18F-rhPSMA-7.3 PET imaging in prostate cancer: (SPOTLIGHT, NCT04186845 ), in men with recurrent disease and (LIGHTHOUSE, NCT04186819 ), in men with newly diagnosed prostate cancer.
  • Blue Earth Diagnostics expanding oncology portfolio encompasses a variety of disease states, including prostate cancer and neuro-oncology.
  • Blue Earth Diagnostics is committed to the timely development and commercialization of precision radiopharmaceuticals for potential use in imaging and therapy.

INTERNATIONAL ISOTOPES INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE-MONTHS 2022

Retrieved on: 
Wednesday, November 16, 2022

IDAHO FALLS, Idaho, Nov. 16, 2022 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three and nine months ended September 30, 2022.

Key Points: 
  • IDAHO FALLS, Idaho, Nov. 16, 2022 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three and nine months ended September 30, 2022.
  • Revenue for the nine-month period ended September 30, 2022, was $8,031,522, as compared to $7,369,922 for the same period in 2021, an increase of approximately 9%.
  • Cost of sales for the three month and nine-month periods ended September 30, 2022, increased approximately 30% and 15% respectively compared to the same periods in 2021.
  • Operating expense increased approximately 22% and 19% for the three- and nine-month periods respectively ended September 30, 2022.

LI-COR Announces the LI-7825 CO2 Isotope Trace Gas Analyzer

Retrieved on: 
Wednesday, November 16, 2022

LINCOLN, Neb., Nov. 16, 2022 /PRNewswire/ -- CO2 isotope measurements are a critical tool for studying climate change and for modelling future climate scenarios. By measuring CO2 isotopes and calculating isotopic ratios, researchers can identify the sources and sinks of atmospheric CO2, evaluate carbon sequestration efforts, partition net ecosystem carbon exchange, and gain insights into biological processes.

Key Points: 
  • LI-COR Inc., a global leader in environmental measurement technology, announced its forthcoming LI-7825 CO2 Isotope Trace Gas Analyzer, which will measure CO2 isotopes in the lab, in the field, and on the move.
  • LINCOLN, Neb., Nov. 16, 2022 /PRNewswire/ -- CO2 isotope measurements are a critical tool for studying climate change and for modelling future climate scenarios.
  • The LI-7825 CO2 Isotope Trace Gas Analyzer measures 12C-CO2, 13C-CO2,18O-CO2, 17O-CO2, and H2O in air and reports CO2 isotopic ratios13C, 18O, and 17Owith high precision and accuracy.
  • LI-COR is an industry-leading environmental technology innovator of high-quality instrument systems for eddy covariance, plant physiology, soil gas flux, light, gas analysis, and greenhouse gas research.

LI-COR Announces the LI-7825 CO2 Isotope Trace Gas Analyzer

Retrieved on: 
Wednesday, November 16, 2022

LINCOLN, Neb., Nov. 16, 2022 /PRNewswire/ -- CO2 isotope measurements are a critical tool for studying climate change and for modelling future climate scenarios. By measuring CO2 isotopes and calculating isotopic ratios, researchers can identify the sources and sinks of atmospheric CO2, evaluate carbon sequestration efforts, partition net ecosystem carbon exchange, and gain insights into biological processes.

Key Points: 
  • LI-COR Inc., a global leader in environmental measurement technology, announced its forthcoming LI-7825 CO2 Isotope Trace Gas Analyzer, which will measure CO2 isotopes in the lab, in the field, and on the move.
  • LINCOLN, Neb., Nov. 16, 2022 /PRNewswire/ -- CO2 isotope measurements are a critical tool for studying climate change and for modelling future climate scenarios.
  • The LI-7825 CO2 Isotope Trace Gas Analyzer measures CO2 isotopes and reports isotopic ratios with high precision.
  • The LI-7825 CO2 Isotope Trace Gas Analyzer measures 12C-CO2, 13C-CO2,18O-CO2, 17O-CO2, and H2O in air and reports CO2 isotopic ratios13C, 18O, and 17Owith high precision and accuracy.